By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Iris International late on Monday announced a deal between its Sample Processing division and Fisher Healthcare to co-market Iris' ThermoBrite Elite instrument for automated fluorescence in situ hybridization sample preparation.

Fisher, a part of Thermo Fisher Scientific, is the first commercial distribution partner for the instrument, Iris said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.